Meet the First Two Penn Memory Center A4 Trial Participants

Myrna Roach and Donald Jackson are the Penn Memory Center’s first two participants in the Anti-Amyloid Treatment in Asymptomatic Alzheimer’s study (the “A4 study”), a historic prevention trial  which is testing whether a new investigational treatment, called an amyloid antibody, can slow memory loss caused by Alzheimer’s disease.

“There’s a family history  of Alzheimer’s disease,” says Ms. Roach, “so I’m interested in helping to find a cure for it, maybe in my lifetime.”

For more information about the A4 trial, click here.


Comments are closed.